<DOC>
	<DOCNO>NCT00602316</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , multifunctional magnetic resonance imaging , may help doctor learn extent disease plan best treatment . PURPOSE : This clinical trial study well multifunctional magnetic resonance imaging work predict breast lesion woman undergo mastectomy breast cancer .</brief_summary>
	<brief_title>Multifunctional Magnetic Resonance Imaging Predicting Breast Lesions Women Undergoing Mastectomy Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine accuracy multifunctional magnetic resonance ( MR ) detecting , localizing , characterize satellite lesion relation index breast tumor order improve definition clinical target volume local excision . OUTLINE : Patients receive injection gadolinium chelate undergo multifunctional magnetic resonance ( MR ) imaging , include dynamic contrast-enhanced MR , hydrogen-MR spectroscopy , diffusion-weighted MRI , ipsilateral breast within 4 week surgery . Patients undergo mastectomy plan . The resected specimen photograph , histopathological analysis perform consist size grade ( pre-invasive invasive disease ) satellite lesion , classification benign satellite lesion , dimension lesion , distance edge index tumor center satellite lesion , distance center surface nipple center lesion .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsyconfirmed invasive ductal carcinoma breast Unifocal disease define clinical examination , mammography , ultrasound Patient must proceed mastectomy Hormone receptor status unknown No T4d multifocal disease ( defined conventional imaging ) Index tumor â‰¤ 4 cm diameter PATIENT CHARACTERISTICS : Menopausal status specify Female No claustrophobia No cup size DD great PRIOR CONCURRENT THERAPY : No prior surgery ipsilateral breast No prior neoadjuvant chemotherapy No prior ferromagnetic implant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>invasive ductal breast carcinoma</keyword>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
</DOC>